1415564-99-6 Usage
General Description
The chemical "5-((4-bromo-2-fluorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylic acid" is a compound with a complex structure. It contains a benzimidazole ring with a carboxylic acid group attached at the 6th position, and a 1-methyl-1H group attached at the 4th position. The compound also contains a 5-((4-bromo-2-fluorophenyl)amino)-4-fluoro substituent. This chemical structure suggests that the compound may have potential pharmacological activity, and could be a valuable target for further research and development in medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 1415564-99-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,1,5,5,6 and 4 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1415564-99:
(9*1)+(8*4)+(7*1)+(6*5)+(5*5)+(4*6)+(3*4)+(2*9)+(1*9)=166
166 % 10 = 6
So 1415564-99-6 is a valid CAS Registry Number.
1415564-99-6Relevant articles and documents
PROCESS OF PREPARATION OF BENZIMIDAZOLE COMPOUNDS
-
Page/Page column 14-15, (2020/10/28)
The application provides process of preparation of benzimidazole compounds such as Binimetinib and Selumetinib. Also, the present application provides intermediates for process of preparation of Binimetinib and Selumetinib.
COMBINATION THERAPY
-
Page/Page column 23, (2013/10/08)
The present invention relates to a pharmaceutical combination comprising a MEK inhibitor compound 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethyoxy)- amide or a pharmaceutically acceptable salt thereof and the IGFIR inhibitor ANTIBODY A, a pharmaceutical composition comprising such combination, methods for treating cancer comprising administration of a therapeutically effective amount of such combination to a subject in need thereof, and uses of such combination for the treatment of cancer.
